Isthmus Partners’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
391,484
+81,222
| +26% | +$496K | 0.28% | 88 |
|
|
2025
Q1 | $2.36M | Buy |
310,262
+3,455
| +1% | +$26.3K | 0.3% | 82 |
|
|
2024
Q4 | $2.95M | Buy |
306,807
+394
| +0.1% | +$3.79K | 0.36% | 75 |
|
|
2024
Q3 | $1.81M | Sell |
306,413
-86,801
| -22% | -$513K | 0.22% | 97 |
|
|
2024
Q2 | $2.72M | Buy |
393,214
+91,714
| +30% | +$636K | 0.32% | 92 |
|
|
2024
Q1 | $2.32M | Buy |
301,500
+85,289
| +39% | +$657K | 0.26% | 100 |
|
|
2023
Q4 | $1.9M | Sell |
216,211
-160,010
| -43% | -$1.4M | 0.25% | 92 |
|
|
2023
Q3 | $2.74M | Sell |
376,221
-34,523
| -8% | -$252K | 0.4% | 51 |
|
|
2023
Q2 | $2.72M | Sell |
410,744
-9,640
| -2% | -$63.7K | 0.37% | 55 |
|
|
2023
Q1 | $1.43M | Buy |
420,384
+35,212
| +9% | +$120K | 0.2% | 101 |
|
|
2022
Q4 | $1.07M | Buy |
385,172
+26,064
| +7% | +$72.5K | 0.16% | 110 |
|
|
2022
Q3 | $1.03M | Buy |
359,108
+41,268
| +13% | +$118K | 0.18% | 102 |
|
|
2022
Q2 | $1.1M | Buy |
317,840
+61,968
| +24% | +$215K | 0.21% | 102 |
|
|
2022
Q1 | $1.21M | Buy |
255,872
+40,681
| +19% | +$192K | 0.2% | 100 |
|
|
2021
Q4 | $1.3M | Buy |
215,191
+5,250
| +3% | +$31.7K | 0.22% | 100 |
|
|
2021
Q3 | $1.27M | Buy |
209,941
+11,989
| +6% | +$72.6K | 0.23% | 98 |
|
|
2021
Q2 | $2.48M | Buy |
197,952
+882
| +0.4% | +$11K | 0.44% | 54 |
|
|
2021
Q1 | $2.03M | Buy |
+197,070
| New | +$2.03M | 0.37% | 58 |
|